|This Slide: #100 of 100|
Slide #100. Brooks Automation — Matrical Bioscience
Brooks Automation (BRKS)
Brooks Automation, Inc. (Nasdaq:BRKS) announced that it signed a definitive agreement to acquire the assets and business of Matrical, Inc. for cash consideration of approximately $10 million. Matrical is a Spokane, Washington-based, privately held company established in 2001 that provides biological sample preparation, management and storage solutions to customers in Agbio, Biotech, Life Science Tools and Pharmaceutical markets. The transaction is subject to customary closing conditions and is expected to be completed within the next two weeks.
Brooks Automation provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
Open the BRKS Page at The Online Investor »
Open the BRKS Page at The Online Investor (in a new window) »
Free BRKS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Strong Buy (3.50 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price:
BRKS Stock Forecast
Based on Zacks ABR data;
powered by Xignite